Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
ImmunoIVD AB
AB
Active
Org 5590180732
Nacka Strand
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2015 · 11 years old
27 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ImmunoIVD AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
ED
Erna Domsgen
Chief Executive Officer
Chief Executive Officer
2020
GL
Gabriel Lars Dan Forssenius
Chief Auditor
Chief Auditor
2020
Former (1)
SP
Staffan Paulie
Chief Executive Officer
Chief Executive Officer
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
LL
Lars-Göran Lennart Hammarström
Board of Directors
Board of Directors
2020
SB
Sten Braesch-Andersen
Chairman
Chairman
2020
SP
Staffan Paulie
Board of Directors
Board of Directors
2020
KO
Kjell Olov Östrand
Deputy Board Member
Deputy Board Member
2020
SM
Stephan Michael Borte
Board of Directors
Board of Directors
2020
Shareholders
As of last annual report
Pabros AB — 87%
87%
Shareholder
Type
Ownership
Votes
Since
Pabros AB
Company
87%
87%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ImmunoIVD AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network